In Dhaka, the capital of Bangladesh, from February 12 to 14, Shenyang DASAN Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "DASAN Pharmaceutical") made a prominent appearance at the Asia Pharma Expo 2025, held at the China-Bangladesh Friendship Exhibition Center. As one of the most influential pharmaceutical industry events in South Asia, DASAN Pharmaceutical, a company focused on drug delivery systems and advanced formulation technology platforms, showcased its leading formulation technology packages, attracting significant attention from numerous industry experts and pharmaceutical companies.

Since its establishment, DASAN Pharmaceutical has focused on the R&D and innovation of drug delivery systems and advanced formulations, committed to providing efficient and reliable solutions for the global pharmaceutical industry. At this exhibition, DASAN Pharmaceutical showcased its latest achievements in solid dosage forms, liquid formulations, sustained and controlled-release formulations, and pediatric mini-tablet formulations. Particularly noteworthy were the customized formulation technology packages tailored to the needs of the Bangladeshi pharmaceutical industry, covering comprehensive technical support from R&D to manufacturing, providing strong technical assurance for local pharmaceutical companies.

During the exhibition, representatives from Shenyang DASAN Pharmaceutical held discussions with leaders from the Bangladesh Directorate General of Drug Administration (DGDA) regarding pharmaceutical import/export trade and market trends. They also visited several local pharmaceutical companies and held in-depth cooperation discussions with their executives. The international market executives from DASAN Pharmaceutical expressed gratitude to the Bangladeshi attendees during the activities, emphasizing that the company will continue to support the development of the Bangladeshi pharmaceutical industry with innovative technologies and high-quality services. Several representatives from Bangladeshi pharmaceutical companies also shared their experiences and achievements from collaborating with DASAN Pharmaceutical, along with their intention for deeper exchanges and trade with the Chinese pharmaceutical industry in the future.

Organized by institutions such as the Bangladesh Association of Pharmaceutical Industries (BAPI), the Asia Pharma Expo 2025 provided a platform for DASAN Pharmaceutical to showcase its leading capabilities in drug delivery systems and advanced formulation technologies, while also expanding cooperation opportunities in the South Asian market. Moving forward, DASAN Pharmaceutical will continue to deepen its presence in the Asian market, leveraging innovative technology as its core driving force to support the sustainable development of the global pharmaceutical industry.